Nidorf S - Search Results

1

Exploration of the regional effects of colchicine in the LoDoCo2 trial.

Budgeon CA, Nidorf S, Mosterd A, Fiolet A, Eikelboom J, O'Halloran S, Joyce D, Schut A, Tijssen J, Cornel JH, Murray K, Thompson P. Budgeon CA, et al. Among authors: nidorf s. Am Heart J. 2024 Dec;278:186-194. doi: 10.1016/j.ahj.2024.09.006. Epub 2024 Sep 21. Am Heart J. 2024. PMID: 39313104 Free article. Clinical Trial.

2

The benefits of beta-blockade at the time of myocardial infarction.

Thompson PL, Nidorf SM, Parsons RW, Jamrozik KD, Hobbs MS. Thompson PL, et al. Among authors: nidorf sm. J Hypertens Suppl. 1991 Dec;9(7):S35-7. doi: 10.1097/00004872-199112007-00009. J Hypertens Suppl. 1991. PMID: 1686460

3

Reduced risk of death at 28 days in patients taking a beta blocker before admission to hospital with myocardial infarction.

Nidorf SM, Parsons RW, Thompson PL, Jamrozik KD, Hobbs MS. Nidorf SM, et al. BMJ. 1990 Jan 13;300(6717):71-4. doi: 10.1136/bmj.300.6717.71. BMJ. 1990. PMID: 1967956 Free PMC article.

4

The creatine kinase ratio: a useful means of detecting early peaking of the creatine kinase curve after acute myocardial infarction.

Nidorf SM, Thompson PL, Byrne A, de Klerk NH. Nidorf SM, et al. Am J Cardiol. 1988 Nov 1;62(13):961-3. doi: 10.1016/0002-9149(88)90902-2. Am J Cardiol. 1988. PMID: 3052015 Clinical Trial. No abstract available.

5

Prognostic significance of an early rise to peak creatine kinase after acute myocardial infarction.

Nidorf SM, Thompson PL, de Klerk NH, Vandongen Y, Katavatis V. Nidorf SM, et al. Am J Cardiol. 1988 Jun 1;61(15):1178-80. doi: 10.1016/0002-9149(88)91150-2. Am J Cardiol. 1988. PMID: 3376879

6

Low-dose colchicine for secondary prevention of cardiovascular disease.

Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Nidorf SM, et al. J Am Coll Cardiol. 2013 Jan 29;61(4):404-410. doi: 10.1016/j.jacc.2012.10.027. Epub 2012 Dec 19. J Am Coll Cardiol. 2013. PMID: 23265346 Free article. Clinical Trial.

7

Targeting the unstable plaque in acute coronary syndromes.

Thompson PL, Nidorf SM, Eikelboom J. Thompson PL, et al. Among authors: nidorf sm. Clin Ther. 2013 Aug;35(8):1099-107. doi: 10.1016/j.clinthera.2013.07.332. Clin Ther. 2013. PMID: 23973042 Review.

8

Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease.

Nidorf SM, Eikelboom JW, Thompson PL. Nidorf SM, et al. J Cardiovasc Pharmacol Ther. 2014 Jan;19(1):45-52. doi: 10.1177/1074248413499972. Epub 2013 Sep 13. J Cardiovasc Pharmacol Ther. 2014. PMID: 24038016 Review.

9

Colchicine for secondary prevention of cardiovascular disease.

Nidorf SM, Eikelboom JW, Thompson PL. Nidorf SM, et al. Curr Atheroscler Rep. 2014 Mar;16(3):391. doi: 10.1007/s11883-013-0391-z. Curr Atheroscler Rep. 2014. PMID: 24425060 Review.

10

Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials.

Verma S, Eikelboom JW, Nidorf SM, Al-Omran M, Gupta N, Teoh H, Friedrich JO. Verma S, et al. Among authors: nidorf sm. BMC Cardiovasc Disord. 2015 Aug 29;15:96. doi: 10.1186/s12872-015-0068-3. BMC Cardiovasc Disord. 2015. PMID: 26318871 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters